What does a positive Human Leukocyte Antigen B27 (HLA B27) test result mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A positive HLA-B27 test is a significant indicator of a potential autoimmune condition, particularly axial spondyloarthritis, but it does not definitively diagnose the disease, as approximately 74% to 89% of patients with axial spondyloarthritis are HLA-B27 positive, while many people with this marker remain asymptomatic 1.

Key Points to Consider

  • The presence of HLA-B27 is strongly associated with axial spondyloarthritis, including ankylosing spondylitis, but it is not exclusive to these conditions 1.
  • A positive HLA-B27 test, combined with symptoms such as chronic back pain, stiffness, and inflammatory markers, can aid in the diagnosis of axial spondyloarthritis 1.
  • The HLA-B27 marker is found in about 8% of the general population, but its presence is significantly higher in individuals with certain autoimmune diseases, suggesting a genetic predisposition 1.
  • The diagnosis of axial spondyloarthritis should be based on a combination of clinical presentation, imaging findings, and laboratory results, including but not limited to HLA-B27 testing 1.

Clinical Implications

  • Patients with a positive HLA-B27 test and symptoms suggestive of axial spondyloarthritis should undergo further evaluation, including imaging studies and potentially MRI to assess for inflammatory changes in the sacroiliac joints and spine 1.
  • Early diagnosis and treatment of axial spondyloarthritis can significantly improve quality of life and reduce disease activity, highlighting the importance of recognizing HLA-B27 as part of a broader diagnostic approach 1.
  • Treatment algorithms for axial spondyloarthritis focus on controlling disease activity and improving quality of life, with biologic agents such as TNF-a antagonists being a standard of care for patients with active disease despite nonsteroidal anti-inflammatory drugs 1.

From the Research

Definition of HLA B27

  • HLA B27 is a member of the HLA class I family of genes in the major histocompatibility complex 2
  • It is involved in presenting peptides to the immune system to defend the organism against microbes targeted by CD8+T cells 2

Association with Ankylosing Spondylitis

  • HLA B27 is strongly associated with ankylosing spondylitis (AS), a highly heritable disease 2, 3
  • About 60%-90% of axSpA patients worldwide carry HLA B27 2
  • The presence of HLA B27 is related to an earlier disease onset and higher family aggregation in Caucasian AS patients 4

Clinical Features

  • HLA B27-positive patients show higher family aggregation and an earlier onset of disease compared with those who are HLA B27 negative 4
  • HLA B27-negative patients present statistically higher disease activity and functional impairment scores, and higher prevalence of arthritis, dactylitis, and extra-articular manifestations 4
  • HLA B27 is associated with uveitis, peripheral joint involvement, and hip joints involvement in AS patients 3

Pathogenic Role

  • The pathogenic role of HLA B27 is unknown, but two broad theories explain its role in AS pathogenesis: the presentation of antigenic peptides to cytotoxic T cells, and the misfolding of HLA B27 leading to endoplasmic reticulum stress and autophagy responses 5
  • HLA B27 can also "behave badly" and lead to proinflammatory effects by binding to innate immune receptors on T, NK, and myeloid cells 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.